Design, Synthesis, Anticancer Evaluation and Molecular Docking Study of Novel 4 H ‐Chromene‐7‐Azaindole‐1,2,3‐Triazole Hybrids
ChemistrySelect · 2024-10 · 9 (38)
DOI: 10.1002/slct.202403149 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 10.10.2024. Verfasst von Vaeshnavi Kashetti und 4 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
A novel library of 4 H ‐chromene‐7‐azaindole‐1,2,3‐triazole hybrids (6 a‐n) utilizing 1‐(prop‐2‐yn‐1‐yl)‐1H‐pyrrolo[2,3‐b]pyridine‐3‐carbaldehyde, 5,5‐dimethylcyclohexane‐1,3‐dione and malononitrile as precursors involving multicomponent synthesis and click chemistry reactions. The title compounds were screened for their invitro anticancer activity against human breast adenocarcinoma (MCF‐7), human cervical cancer (HeLa) and prostate cancer (DU‐145) cells by using Doxorubicin as standard reference. The activities of all compounds could be more effecting against HeLa cells. Compound 6 g with 3‐nitro substitution on phenyl ring displayed outstanding activity against all three cell lines with IC 50 value of 6.67±0.39 μM (MCF‐7), 4.49±0.32 μM (HeLa) and 10.38±0.42 μM (DU‐145) than reference drug. The compound 6 h with methyl group in ortho position of phenyl ring showed best activity with IC 50 value of 7.32±0.62 μM, 6.87±0.33 μM and 15.40±0.60 μM against MCF‐7, HeLa and DU‐145 cells respectively. Performed molecular docking study against crystal structure of EGFR obtained favorable binding interactions showing consistency with experimental results.
Zitieren
APA
Kashetti, V., Vanga, M. K., Chevula, K., Kuchana, V., & Manga, V. (2024). Design, Synthesis, Anticancer Evaluation and Molecular Docking Study of Novel 4 H ‐Chromene‐7‐Azaindole‐1,2,3‐Triazole Hybrids. ChemistrySelect, 9(38). https://doi.org/10.1002/slct.202403149
Vancouver
Kashetti V, Vanga MK, Chevula K, Kuchana V, Manga V. Design, Synthesis, Anticancer Evaluation and Molecular Docking Study of Novel 4 H ‐Chromene‐7‐Azaindole‐1,2,3‐Triazole Hybrids. ChemistrySelect. 2024;9(38). doi:10.1002/slct.202403149
BibTeX
@article{Kashetti2024,
author = {Kashetti, Vaeshnavi and Vanga, Murali Krishna and Chevula, Kishan and Kuchana, Vinutha and Manga, Vijjulatha},
title = {Design, Synthesis, Anticancer Evaluation and Molecular Docking Study of Novel 4 H ‐Chromene‐7‐Azaindole‐1,2,3‐Triazole Hybrids},
journal = {ChemistrySelect},
year = {2024},
volume = {9},
number = {38},
doi = {10.1002/slct.202403149}
}
EUVIMED